Algo version: 0.98b
Li Kang Biomedical Co Ltd is listed at the TWO Exchange
Li Kang Biomedical Co Ltd [6242.TWO]
TWO Sector: Industry:

Is Li Kang Biomedical Co Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Li Kang Biomedical Co Ltd pays dividends. Last time was Friday 26th of July 2024 where the investors holding the stock on Thursday 20th of June 2024 were paid TWD2.5 per share. Over the last 9 times between 2016 and 2024, Li Kang Biomedical Co Ltd has paid TWD14.623207 with an average of TWD1.62 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Li Kang Biomedical Co Ltd 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD31.95, you would have made a profit of TWD10.85 per share or 33.96%

No, the average daily trading liquidity for Li Kang Biomedical Co Ltd is TWD7 500 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Li Kang Biomedical Co Ltd has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.54, the company's ability to pay off the debt is good. Li Kang Biomedical Co Ltd has a good net profit margin of 14.30% and should have high tolerances against inflation.

We have calculated the inflation risk for Li Kang Biomedical Co Ltd to be low [0.1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.